SenoRx Inc., an Aliso Viejo medical device maker, on Tuesday said it narrowed its second-quarter loss, its first full earnings after its $45 million initial public offering in March.
SenoRx said it lost $2.1 million in the quarter, down from $6.5 million a year earlier.
In a release, the breast biopsy device maker said the loss reduction came from a swing in interest income resulting from its IPO proceeds as well as other gains.
The company’s revenue was up 28% to $8.1 million from 2006’s second quarter.
Analysts had expected SenoRx to lose $1.9 million on revenue of $8 million.
